Teachers Retirement System of the State of Kentucky’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$622K Buy
+5,601
New +$506K ﹤0.01% 1365
2021
Q1
Sell
-31,979
Closed -$951K 1784
2020
Q4
$951K Sell
31,979
-3,600
-10% -$91.5K 0.01% 859
2020
Q3
$771K Hold
35,579
0.01% 880
2020
Q2
$793K Hold
35,579
0.01% 870
2020
Q1
$542K Hold
35,579
0.01% 947
2019
Q4
$817K Buy
+35,579
New +$790K 0.01% 940

Other funds holding RYTM

Teachers Retirement System of the State of Kentucky's RYTM Position: Q2 2026 in Review

Teachers Retirement System of the State of Kentucky opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 5,601 shares worth $622K. The stake represents ﹤0.01% of the portfolio and ranks #1365 among its holdings. This is a return to the name: Teachers Retirement System of the State of Kentucky previously reported a position in RYTM as recently as Q4 2020.

Teachers Retirement System of the State of Kentucky first reported a position in RYTM in Q4 2019 and has held it in 6 quarters since. The position peaked at $951K in Q4 2020. 151 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Teachers Retirement System of the State of Kentucky held 5,601 shares of Rhythm Pharmaceuticals worth $622K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Teachers Retirement System of the State of Kentucky position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Teachers Retirement System of the State of Kentucky's portfolio in Q2 2026, its #1365 holding.
  • Teachers Retirement System of the State of Kentucky first reported a position in Rhythm Pharmaceuticals in Q4 2019 and has held it in 6 quarters since.
  • Teachers Retirement System of the State of Kentucky's Rhythm Pharmaceuticals position peaked at $951K in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Teachers Retirement System of the State of Kentucky's 13F filing for Q2 2026, filed 12 Aug 2026.